| Latest Forum Topics / DISA Last:0.002 -- |
 Post Reply
|
|
Big Break thru for Equition
|
|||
|
Joelton
Supreme |
09-May-2024 07:36
|
||
|
x 0
x 0 Alert Admin |
DISA&rsquo s CEO: Visioning Opportunities and Growth in Regional Eye Care Markets
DISA, under CEO Eddie Chng, leverages smart visual tests and AI to meet the rising demand for eye care in aging populations, driven by medical advancements.
With ageing populations&rsquo greater need for eye care and medical advances that scan retinas to detect diseases, digital solutions firm DISA is harnessing these opportunities with smart visual test devices and artificial intelligence (AI). Its CEO Eddie Chng shares more.
DISA&rsquo s Chief Executive Officer Eddie Chng has a new growth vision for his digital solutions company. Its subsidiary, Digital Life Line, has recently completed the first trial deployment of its Automated Visual Acuity Test (&ldquo AVAT&rdquo ) device in a major public hospital in Singapore, with ongoing trials with other public and private eye clinics across Singapore to further expand its market presence.
Globally, DISA&rsquo s AVAT device is one of the first devices that can automate ophthalmology screening, which is essential for eye care related diseases.
Visual acuity tests &ndash where patients read letters on a chart at a distance &ndash are common and essential in eye clinics, but usually require trained staff and at least six metres between the person and chart. With the AVAT device, which fits on a desk half the size of an office table, patients can just look into it to see characters and press a keypad accordingly to gauge their eyesight, improving accessibility and convenience as well as enhanced diagnostic accuracy.
Chng says: &ldquo With the ageing population in Singapore and other regional countries, vision tests will be a big part of healthcare. With our devices, visual testing can be self-conducted or done with only a little help from trained operators. These innovations have great promise for both healthcare and our business.&rdquo
&ldquo By deploying our AVAT devices, hospitals and eye specialist centres can scale up testing with minimal costs, space and manpower. In addition, we can improve accessibility in communities where people can get eye screenings more regularly and conveniently in their neighbourhood optical shops.&rdquo
Harnessing Artificial intelligence for early detection of age-related diseases
The role of Artificial Intelligence (AI) and deep learning models is attracting significant global interest in the field of ophthalmology in recent years as it offers potential for recognising signs of medical conditions in retinal images, which have been linked to non-eye-related diseases like kidney and heart conditions.
Since such conditions may not exhibit symptoms in the early stages, AI-empowered retinal imaging solutions can play a role in the early detection and management of multiple health conditions, further cementing its value in community screening efforts.
Based on a proprietary hardware-agnostic, deep learning algorithm on various eye pathologies, Digital Life Line&rsquo s AI-based retinal imaging solution, AI-VI, also has the ability to integrate additional AI-tools to detect other age-related medical conditions.
Chng adds, &ldquo Given the non-invasive and affordable nature of retinal imaging, we believe that it will become an important health screen tool in the near future and we aim to harness such opportunities with the expanding capabilities of AI-based retinal imaging solution.&rdquo
An eye on overseas expansions
With a clear commercialisation strategy based on a &ldquo Hardware-as-a-Service&rdquo and &ldquo Software-as-a-Service&rdquo business model, DISA has also fielded growing interest in the AVAT device from overseas eye clinics, underlining the potential for widespread adoption in the Asia-Pacific.
Vietnam has been identified as a key target market because of the country&rsquo s ageing population of nearly 100 million people and rising demand for eye care that has been underserved by limited resources.
To accelerate its growth plans in this area, DISA has signed a memorandum of understanding with local eye care specialist Alina Vision to install the AVAT device, and plans to expand the range for testing solutions by adding retina scans and analysis powered by AI. Chng says: &ldquo The image of your retina can reveal a lot about one&rsquo s health, hence ophthalmologists can do more than just ophthalmology with our AVAT and AI-based retinal imaging solution. This benefits their practice, because they can offer more services and have new streams of income without the need for significant resources or investments.&rdquo
The firm is in talks with Vietnam&rsquo s top hospitals, and will look into entering other regional markets in accordance to their growth plans. He adds that most hospitals do not have ophthalmologists on site. &ldquo However, with the advent of AI and retina imaging, not to mention ageing populations, there is a very high possibility that many of them will want to acquire such capabilities, to create or expand their own range of ophthalmology services.&rdquo
&ldquo For hospitals and specialist eye clinics, it&rsquo s also about optimising economic value. They can set aside the space that&rsquo s needed for the conventional vision tests, or they can have a smaller table and our equipment on top of it for people to do their tests. I think that for many hospitals, they will want to create as much value as they can out of their limited healthcare space.&rdquo
Lessons from a life of entrepreneurship
For Chng, the timely foray into eye care is the latest considered move in a career that has had many of them. A serial entrepreneur who worked in Hong Kong and China, his journey with DISA began when he invested in, and was appointed to run a SGX-listed company that eventually renamed DISA, short for digital safety, and pivoted to the growing digital security industry.
DISA&rsquo s products include a digital solution that prevents theft by making electronic devices non-functional until activated by a code provided at point of purchase. It counts an American retail giant as a client, among others.
Chng says that the willingness to try new things is crucial to making a mark in any sector. He explains: &ldquo People tend to be more curious and daring when they&rsquo re young, and become less so as they get older. But you can&rsquo t make it big if you don&rsquo t take risks, so maintaining the status quo shouldn&rsquo t be an option. I&rsquo ve made mistakes, but you pick yourself up and keep going.&rdquo
He also highlights the importance of choosing and retaining the right talent. &ldquo Just look at me. I&rsquo m not a doctor by training, but I can hire people with the expertise I need. As management, you rely on your people. That&rsquo s why you must ensure you have the right ones. I&rsquo ve learned that over the years in my many businesses.&rdquo
Looking ahead, he points to the need for financial prudence. While firms have had access to cheaper funding in the past 10 to 15 years because of low interest rates, that is no longer the case, he says.
&ldquo Make sure you leave yourself enough of a financial runway so that you have options. If you&rsquo re careful in managing your capital, overheads and spending, you have more choices, including to capitalise on opportunities. Apart from that, be laser-focused on the industry and markets that you want to make progress in, and you will give yourself the best chance of success.&rdquo
|
||
| Useful To Me Not Useful To Me | |||
|
MrBear12
Supreme |
01-May-2024 14:44
Yells: "A retired bear will still always be a bear" |
||
|
x 0
x 0 Alert Admin |
After consolidation still under five cents. The joker of the SGX. Consolidate only because one cannot stay at 0.2 cents. You move up one, it' s 50% gain (or loss). You move down, it is 100% loss (or gain). How can this counter be ever traded? Answer: Via Consolidation |
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
Joelton
Supreme |
01-May-2024 13:53
|
||
|
x 0
x 0 Alert Admin |
DISA: Share consolidation (15 to 1)
The board of directors (the &ldquo Board&rdquo or &ldquo Directors&rdquo ) of the Company is pleased to announce a proposed share consolidation of every fifteen (15) existing issued ordinary shares in the capital of the Company (&ldquo Shares&rdquo ) held by shareholders of the Company (the &ldquo Shareholders&rdquo ) as at a record date to be determined by the Directors (&ldquo Record Date&rdquo ) into one (1) ordinary share (collectively, referred to as the &ldquo Consolidated Shares&rdquo and each, a &ldquo Consolidated Share&rdquo ), fractional entitlements to be disregarded (the &ldquo Proposed Share Consolidation&rdquo ).
|
||
| Useful To Me Not Useful To Me | |||
|
Joelton
Supreme |
23-Apr-2024 10:39
|
||
|
x 0
x 0 Alert Admin |
DISA: Signed MOU with Alina Vision for the Trial Deployment of Automated Visual Acuity Test Device in Vietnam
▪ The Memorandum of Understanding (&ldquo MOU&rdquo ) is a major milestone in the Group&rsquo s commercialisation strategy and marks DLL&rsquo s maiden overseas expansion of its
Automated Visual Acuity Test Device (&ldquo AVAT&rdquo )
▪ By 2035, Vietnam will be an aged society that makes it one of the fastest-aging countries in the world where there will be increasing prevalence of age-related eye diseases, according to The World Bank Report
▪ Globally, the Group&rsquo s AVAT is one of the first devices that can automate ophthalmology screening, which is essential for eye-care related diseases
▪ DLL recently completed the first trial deployment of the AVAT device in a major public hospital in Singapore
▪ Video demo of AVAT: https://www.youtube.com/watch?v=GrQSHMd35PM
DISA Limited (the &ldquo Company&rdquo ) is pleased to share that its subsidiary company, DLL, has announced today on the signing of a MOU with Alina Eye Hospital Social Enterprise Company Limited - Alina Eye Clinic Quang Ninh (&ldquo Alina Vision&rdquo ) that involves the trial deployments of AVAT at Alina Vision hospitals in Vietnam.
Incorporated in 2021, DLL is a Singapore-based ISO13485-certified medical technology company that provides digital, AI-powered diagnostic ophthalmology solutions to enable community-based vision screening for early detection and treatment of vision impairment as well as non-invasive diagnostic solutions.
Founded by an international development organisation, The Fred Hollows Foundation, in 2018, Alina Vision, which currently operates two eye hospitals in the underserved Vietnamese ophthalmology market, provides affordable and high-quality eye care services for people across all income levels to combat avoidable blindness and treat eye diseases. Over the past five years, The Fred Hollows Foundation and Rohto Pharmaceutical, a leading eyecare company in Japan, have provided financial support, eye surgery training and clinical assistance to Alina Vision to grow the organisation from inception to more than 80 employees across the two eye hospitals.
In 2013 alone, Alina Vision has completed more than 2,800 cataract surgeries and it has a vision to become a dominant and market leading service provider in the Vietnamese ophthalmology market with a chain of eye hospitals across Vietnam, which can cater to the rising demand for the cataract surgeries that has been undeserved by limited medical resources domestically.
Notably, the investment of industry specialist growth capital investor, TVM Capital Healthcare, an emerging markets-focused healthcare private equity firm headquartered in Singapore and Dubai, with offices in Riyadh, Boston, Munich, and Ho Chi Minh City, will provide Alina Vision with access to operational, clinical, training, and management resources, in addition to the equity investment.
Developed by the Department of Ophthalmology at the National University Hospital (&ldquo NUH&rdquo ) and Centre for Innovation and Precision Eye Health at the Yong Loo Lin School of Medicine, National University of Singapore (&ldquo NUS Medicine&rdquo ), AVAT addresses the increasing demand to decentralise the existing care model of conducting eye screening and monitoring of eye diseases. By incorporating automation and digitalisation, AVAT has allowed for more efficient vision testing workflow with minimal costs and manpower resources.
Leveraging on the proprietary optics and intelligent software programming, AVAT recapitulates the standard 6-meter visual acuity test within a tabletop footprint and allows for patients to perform the assessment without the need for trained staff.
The system provides Snellen&rsquo s Tumbling E test formats in multiple languages. It also has a pinhole test feature to assess if the &ldquo poor vision&rdquo is the result of refractive error and if so, it will guide the patients on the subsequent steps to be taken. Results can be easily integrated into electronic medical records, thereby cutting down on human error during data input.
By reducing the need for trained operators, AVAT not only addresses the manpower shortages in the healthcare systems, but also ensures a consistent level of test quality and eliminates human error. Patients have indicated a perference for the AVAT testing format, as it has the potential to significantly reduce wait times and remove the major bottleneck in the clinic workflow.
&ldquo We are delighted to sign this MOU with Alina Vision and are honoured to have given the opportunity to deploy AVAT outside of Singapore, which is in line with DLL&rsquo s commercialisation strategy and to improve accessibility and convenience for accurate vision screening through automation and technology innovation.&rdquo Mr. Eddie Chng, the Managing Director and Chief Executive Officer of the Group said, &ldquo To-date, AVAT has been used on over 2,000 patients in hospitals, schools and community settings. Its performance has been validated to have excellent correlation with standard tests, while outperforming similar devices that claim to reduce the space requirement.&rdquo
|
||
| Useful To Me Not Useful To Me | |||
|
Joelton
Supreme |
17-Apr-2024 12:55
|
||
|
x 0
x 0 Alert Admin |
DiSa Broadens its Digital Safety Solutions within the United States of America (&ldquo USA&rdquo )&rsquo s Retail Industry to Reduce Retail Theft Harnessing Opportunities with New Innovations for the Multi-Billion Dollar Retail Industry in the USA
▪ Fraud and abuse accounted for nearly 14% of total retail returns in 2023, totaling a loss of $101 billion in the USA, an increase of 20%, year-on-year1
▪ The adoption of DiSa&rsquo s digital safety solutions has proven to reduce retail fraud for its customers in the USA
▪ DiSa&rsquo s new digital safety solution is being evaluated for deployment in smart devices such as smart car, smart home, video game systems, among others
▪ Currently in discussion with a leading RFID provider to jointly market an innovative tracking and inventory management solution to one of the largest retailers in the world
▪ DiSa has been granted a patent by the United States Patent and Trademark Office on 12 March 2024 for its Smart Case
DISA Limited (&ldquo DiSa&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ) is pleased to share the recent business updates of DiSa Digital Safety Pte.
Ltd. (&ldquo DiSa DS&rdquo ), a wholly-owned subsidiary of the Company, that specialises in anti-theft, anti-fraud digital safety solutions (&ldquo Digital Safety Solutions&rdquo ) for the multi-billion dollar retail industry in the USA.
Fraud and abuse in retail returns continue to rise at a concerning pace in the USA, according to the annual 2023 Consumer Returns in the Retail Industry Report from the National Retail Federation (NRF) and Appriss Retail. This was evidenced in one of the world&rsquo s largest retailers that DiSa DS has been working with since 2014.
DiSa DS made its maiden foray into the USA retail market in 2014 with the pilot test of its Digital Safety Solutions at some of the stores of one of the largest retailers in the world. After rigorous testing by Loss Prevention Research Council, USA, DiSa DS rolled out this Digital Safety Solution to all of the stores in 2017 and also launched its Single-Scan Serialization (&ldquo 3S&rdquo ) Digital Safety Solution to prevent return fraud within the same retailer in the same year.
Demonstrating its technological capabilities in Digital Safety Solutions, DiSa DS introduced the Pointof-Sale Activation (&ldquo PoSA&rdquo ) smart lock which is the first digital asset-protection solution that removes the benefit of stealing by making consumer electronic devices non-functional until the point of payment by the consumer at retail stores. For this Digital Safety Solution, DiSa DS was named first place winner for the 2017 (R) Tech Asset Protection: Innovation Award by the Retail Industry Leaders Association, USA for its PoSA solution in 2017.
To harness more opportunities targeting various segments within USA&rsquo s retail industry, DiSa DS has been expanding and broadening its portfolio of Digital Safety Solutions to prevent and resolve the issues relating to retail theft, fraud and abuse.
Mr. Eddie Chng, the Managing Director and Chief Executive Officer of DiSa said, &ldquo With persistent inflationary environment and uncertain economic prospects, retail theft and fraud continue to be a widespread and growing concern within the retail industry in the USA.
With our Digital Safety Solutions that are proven and scalable, retailers can effectively prevent and deter retail theft and fraud, enhance their employee safety and improve their business performance consistently.&rdquo
3S
The increase in retail theft and fraud has resulted in an increase in 3S-protected product categories over the past 12 months. The price points on new product categories range from as low as US$20 to as high as US$200 per item, where the low price point items are smaller and easier to steal and thus see a higher attempted theft and fraud rate, while the higher price point items are larger and harder to steal, but the high cost makes a larger impact to the retailer when stolen.
Supplier Serialized Service Activation (&ldquo 3SA&rdquo )
DiSa DS is also partnering with the brand owners in a new technological innovation to combat theft and fraud. When a consumer attempts to use a 3SA-protected item, it connects with the brand owner&rsquo s server to verify the sales status of the item, which will validate the purchase via DiSa DS&rsquo s sales data in real-time. If the item is verified as purchased, the item is activated remotely without the legitimate customer knowing what was happening behind the scenes. If the item is verified as unsold, the brand owner can remotely deactivate the item for usage until the consumer produces a valid sales receipt as proof of purchase.
This solution is currently being evaluated for deployment in the retailing of smart devices such as smart cars, smart home, and video game systems, among others.
&ldquo With the decrease in retail sales revenue resulting from increased retail theft, the interest for DiSa Digital Safety Solutions continues to increase progressively. When sales are down, retailers are realizing that an easier way to improve business performance is to decrease theft and returns fraud, Mr. Jacob Gulbransen, the Vice President of USA Sales and Operations of the Group stated, &ldquo In response to the needs of the retailers, DiSa has pioneered a new customer-friendly version of PoSA smart lock, known as 3SA, to help the retailers to combat return fraud.&rdquo
FreshCounts
In addition, DiSa DS is working with one of the world&rsquo s largest baby formula sellers to enhance the protection of baby formula using one of its Digital Safety Solutions, FreshCounts. After a successful test with the retailer, DiSa DS is working closely with every major US baby formula manufacturer to roll out and integrate FreshCounts within its system.
As the baby formula industry continues to face inventory challenges stemming from previous products recalls and increased FDA regulations, FreshCounts provides a more efficient and effective way for brand owners to enhance food safety for infants while improving inventory management and reducing product effects of recalls. As the brand owners continue to work towards integration, confidence is
high that they will soon be able to serialize despite the continued inventory challenges slowing changes.
Radio Frequency Identification (&ldquo RFID&rdquo ) + DiSa Smart Barcode
DiSa DS is currently in discussion with a leading RFID provider to jointly market an innovative tracking and inventory management solution to one of the largest retailers in the world.
DiSa Smart Case
DiSa has been granted a patent by the United States Patent and Trademark Office for its Smart Case on 12 March 2024.
More recently, DiSa DS has debuted its DiSa Smart Case to help combat retail theft as retailers are facing increased retail theft. Designed for simplicity that facilitates the ease of use for both consumers and retailers, DiSa&rsquo s Smart Case allows remote and programmable locking and unlocking on a 24/7 basis to keep merchandise protected and available with the push of a button.
This solution has generated significant interest within the convenience store market through partnerships with the Asian American Trade Associations Council (&ldquo AATAC&rdquo ) and regional convenience store chains, where it is currently being tested in several convenience stores across the USA.
In an announcement released by AATAC to its members last month, Mr. Tony Patel, the Associate Director of AATAC, stated, &ldquo As positive reception to the DiSa Smart Case continues to grow within our network, we expect to soon be able to incorporate this device into hundreds of stores that belong to our Distribution Resolution and Integration Program (&ldquo DRIP&rdquo ). This evolution would allow our delivery representatives to comfortably activate our DRIP sites with higher valued items for resale.&rdquo
|
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
Joelton
Supreme |
16-Apr-2024 10:00
|
||
|
x 0
x 0 Alert Admin |
DiSa' s DLL Completes Trial Deployment of Automated Visual Acuity Test Device in a Major Public Hospital in Singapore, Accelerating Commercialisation Efforts with Strategic New Hires
▪ Globally, the Group&rsquo s Automated Visual Acuity Test (&ldquo AVAT&rdquo ) is one of the first devices that can automate ophthalmology screening, which is essential for eyecare related diseases
▪ Recently completed the first trial deployment of its AVAT device in a major public hospital in Singapore
▪ Ongoing trials with other public and private eye clinics across Singapore to further expand market presence
▪ New engineering and regulatory specialists added to the team to accelerate commercialisation efforts
▪ Video demo of AVAT at https://www.youtube.com/watch?v=GrQSHMd35PM
DISA Limited (&ldquo DISA&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ) is pleased to share the recent milestones of Digital Life Line Pte. Ltd.
(&ldquo DLL&rdquo ), a subsidiary of DiSa Digital Safety Pte. Ltd., a wholly owned subsidiary of the Company. Incorporated in 2021, DLL is a Singapore-based ISO13485-certified medical technology company that provides digital, AI-powered diagnostic ophthalmology solutions to enable community-based vision screening for early detection and treatment of vision impairment.
AVAT is the result of years of dedicated research and development work by the Department of Ophthalmology at the National University Hospital (&ldquo NUH&rdquo ) and Centre for Innovation and Precision Eye Health at the Yong Loo Lin School of Medicine, National University of Singapore (&ldquo NUS Medicine&rdquo ) to alleviate operational challenges with visual acuity (&ldquo VA&rdquo ) testing.
Commercial Deployment of AVAT Expected in 2nd Quarter of 2024
DLL has recently completed the first trial deployment of its AVAT device in a major public hospital in Singapore, with ongoing trials with other public and private eye clinics across Singapore to further expand its market presence.
Based on a &ldquo Hardware-as-a-Service&rdquo business model, AVAT&rsquo s first commercial deployment is expected in the second quarter of 2024, which also marks a significant step forward towards DLL&rsquo s mission to improve accessibility and convenience for accurate vision screening via automation and technology innovation.
Globally, AVAT is one of the first devices that can automate ophthalmology screening. With its adaptive test algorithm, proprietary afocal optics, and user-friendly interface within a tabletop footprint, AVAT offers precise and efficient vision testing, contributing to enhanced patient care and diagnostic accuracy.
Mr. Eddie Chng, the Managing Director and Chief Executive Officer of the Group said, &ldquo Within 8 months, we have made significant progress in the field of ophthalmology screening and diagnostics. Our team' s dedication and ingenuity have been instrumental in achieving these milestones, and I am incredibly proud of their hard work and commitment to excellence.
With the successful deployment of our AVAT device in Singapore, it is another testament to our commitment to deliver tangible value to our clinical partners and patients with our technology innovations.
To meet the increasing demand for eye-related healthcare needs, we aim to empower eyecare professionals with the DLL&rsquo s growing portfolio of advanced diagnostic tools, improving patient outcomes and lowering healthcare costs by facilitating timely interventions and personalised care."
&ldquo Building on the work by clinician innovators and nurse practitioners, we are already witnessing positive feedback from healthcare professionals and patients alike, underscoring the value and effectiveness of our innovative solution,&rdquo said Dr. Poh Weijie, the Chief Scientist of DLL. &ldquo We are also pleased to report growing interest from overseas eye clinics, indicating the potential for widespread adoption of AVAT in the Asia-Pacific. The recognition and enthusiasm demonstrated by international healthcare institutions validate the efficacy and reliability of our technology on a global scale, positioning us as a vital asset in ophthalmic
diagnostics.&rdquo
Welcomes New Engineering and Regulatory Specialists to DLL
As part of DLL&rsquo s market expansion strategy, the Group is delighted to welcome two new valuable additions to DLL&rsquo s team, where their expertise and insight will be instrumental in further enhancing the functionality and usability of DLL&rsquo s medical device solutions, ensuring alignment with the evolving needs of healthcare professionals and patients.
Firstly, the Group welcomes Mr. Muhammad Azri Bin Razali, who has joined DLL as Chief Engineer. Having worked with clinicians to develop solutions that address gaps in diagnosis and treatment, Mr. Muhammad Azri has more than a decade of experience in hardware and software development with deep knowledge in multiple domains, including image processing, rapid prototyping and translational research in ophthalmology.
Secondly, the Group has enlisted the expertise of Dr. Geetha Ganesh, a seasoned regulatory affairs specialist, to navigate the complex landscape of medical device regulations and compliance. Dr. Ganesh has been extensively involved for the last 20 years in the fields of global regulatory affairs of medical devices, drugs, and pharmaceutical products, including having completed regulatory audits that cover ISO 13485, PIC GMP, WHO-GMP, CFR (Code of Federal Regulation), TGA (TGA &ndash Australia Medical Device Approval), MDR/ IVDR (CE certification), Singapore (SS620), Good Distribution Practice of Medical Devices in Malaysia (GDPMD), GLP, MDSAP, ISO 15189 and GDP. Her profound understanding of regulatory requirements will be vital in accelerating DLL&rsquo s commercialisation efforts and facilitating regulatory approval processes for its products and services.
Mr. Eddie Chng added, &ldquo Coupled with the burgeoning interest from overseas eye clinics and the strategic additions to our team, we are optimistic that we are well positioned to leverage these milestones as catalysts for new growth opportunities ahead.&rdquo
|
||
| Useful To Me Not Useful To Me | |||
|
MrBear12
Supreme |
16-Apr-2024 09:59
Yells: "A retired bear will still always be a bear" |
||
|
x 0
x 0 Alert Admin |
WB would not even have touched this with a pole. Would his disciple do so? | ||
| Useful To Me Not Useful To Me | |||
|
WBdisciple
Master |
16-Apr-2024 08:04
|
||
|
x 0
x 0 Alert Admin |
This counter caught my eye.....recent news looks positive for the Group with their expansion in healthcare technology within Singapore market. Eye checks are impt for an ageing population...and not only that, young children need it as well...with high manpower costs in Singapore, their technology looks like a good fit: https://links.sgx.com/FileOpen/Disa%20-%20DLL%20Business%20Updates-8April2024.ashx?App=Announcement& FileID=795123 |
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
SmallSmall
Supreme |
08-Apr-2024 14:32
|
||
|
x 0
x 0 Alert Admin |
For those interested. Not vested NEWS RELEASE: DLL Completes Trial Deployment of Automated Visual Acuity Test Device in a Major Public Hospital in Singapore, Accelerating Commercialisation Efforts with Strategic New Hires ▪ Globally, the Group&rsquo s Automated Visual Acuity Test (&ldquo AVAT&rdquo ) is one of the first devices that can automate ophthalmology screening, which is essential for eyecare related diseases ▪ Recently completed the first trial deployment of its AVAT device in a major public hospital in Singapore ▪ Ongoing trials with other public and private eye clinics across Singapore to further expand market presence ▪ New engineering and regulatory specialists added to the team to accelerate commercialisation efforts ▪ Video demo of AVAT at https://www.youtube.com/watch?v=GrQSHMd35PM SINGAPORE &ndash 8 April, 2024 &mdash DISA Limited (&ldquo DISA&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ) is pleased to share the recent milestones of Digital Life Line Pte. Ltd. (&ldquo DLL&rdquo ), a subsidiary of DiSa Digital Safety Pte. Ltd., a wholly owned subsidiary of the Company. Incorporated in 2021, DLL is a Singapore-based ISO13485-certified medical technology company that provides digital, AI-powered diagnostic ophthalmology solutions to enable community-based vision screening for early detection and treatment of vision impairment. AVAT is the result of years of dedicated research and development work by the Department of Ophthalmology at the National University Hospital (&ldquo NUH&rdquo ) and Centre for Innovation and Precision Eye Health at the Yong Loo Lin School of Medicine, National University of Singapore (&ldquo NUS Medicine&rdquo ) to alleviate operational challenges with visual acuity (&ldquo VA&rdquo ) testing. Commercial Deployment of AVAT Expected in 2nd Quarter of 2024 DLL has recently completed the first trial deployment of its AVAT device in a major public hospital in Singapore, with ongoing trials with other public and private eye clinics across Singapore to further expand its market presence. Based on a &ldquo Hardware-as-a-Service&rdquo business model, AVAT&rsquo s first commercial deployment is expected in the second quarter of 2024, which also marks a significant step forward towards DLL&rsquo s mission to improve accessibility and convenience for accurate vision screening via automation and technology innovation. Globally, AVAT is one of the first devices that can automate ophthalmology screening. With its adaptive test algorithm, proprietary afocal optics, and user-friendly interface within a tabletop footprint, AVAT offers precise and efficient vision testing, contributing to enhanced patient care and diagnostic accuracy. Mr. Eddie Chng, the Managing Director and Chief Executive Officer of the Group said, &ldquo Within 8 months, we have made significant progress in the field of ophthalmology screening and diagnostics. Our team' s dedication and ingenuity have been instrumental in achieving these milestones, and I am incredibly proud of their hard work and commitment to excellence. With the successful deployment of our AVAT device in Singapore, it is another testament to our commitment to deliver tangible value to our clinical partners and patients with our technology innovations. To meet the increasing demand for eye-related healthcare needs, we aim to empower eyecare professionals with the DLL&rsquo s growing portfolio of advanced diagnostic tools, improving patient outcomes and lowering healthcare costs by facilitating timely interventions and personalised care." &ldquo Building on the work by clinician innovators and nurse practitioners, we are already witnessing positive feedback from healthcare professionals and patients alike, underscoring the value and effectiveness of our innovative solution,&rdquo said Dr. Poh Weijie, the Chief Scientist of DLL. &ldquo We are also pleased to report growing interest from overseas eye clinics, indicating the potential for widespread adoption of AVAT in the Asia-Pacific. The recognition and enthusiasm demonstrated by international healthcare institutions validate the efficacy and reliability of our technology on a global scale, positioning us as a vital asset in ophthalmic diagnostics.&rdquo Welcomes New Engineering and Regulatory Specialists to DLL As part of DLL&rsquo s market expansion strategy, the Group is delighted to welcome two new valuable additions to DLL&rsquo s team, where their expertise and insight will be instrumental in further enhancing the functionality and usability of DLL&rsquo s medical device solutions, ensuring alignment with the evolving needs of healthcare professionals and patients. Firstly, the Group welcomes Mr. Muhammad Azri Bin Razali, who has joined DLL as Chief Engineer. Having worked with clinicians to develop solutions that address gaps in diagnosis and treatment, Mr. Muhammad Azri has more than a decade of experience in hardware and software development with deep knowledge in multiple domains, including image processing, rapid prototyping and translational research in ophthalmology. Secondly, the Group has enlisted the expertise of Dr. Geetha Ganesh, a seasoned regulatory affairs specialist, to navigate the complex landscape of medical device regulations and compliance. Dr. Ganesh has been extensively involved for the last 20 years in the fields of global regulatory affairs of medical devices, drugs, and pharmaceutical products, including having completed regulatory audits that cover ISO 13485, PIC GMP, WHO-GMP, CFR (Code of Federal Regulation), TGA (TGA &ndash Australia Medical Device Approval), MDR/ IVDR (CE certification), Singapore (SS620), Good Distribution Practice of Medical Devices in Malaysia (GDPMD), GLP, MDSAP, ISO 15189 and GDP. Her profound understanding of regulatory requirements will be vital in accelerating DLL&rsquo s commercialisation efforts and facilitating regulatory approval processes for its products and services. Mr. Eddie Chng added, &ldquo Coupled with the burgeoning interest from overseas eye clinics and the strategic additions to our team, we are optimistic that we are well positioned to leverage these milestones as catalysts for new growth opportunities ahead.&rdquo ------------------End----------------- |
||
| Useful To Me Not Useful To Me | |||
|
Joelton
Supreme |
03-Apr-2024 10:15
|
||
|
x 0
x 0 Alert Admin |
DISA: Increase in equity interest of Singapore-based health-tech company, Digital Life Line
The Board of Directors (the &ldquo Board&rdquo or &ldquo Directors&rdquo ) of DISA Limited (the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ) wishes to announce that the Company has on 2 April 2024, through its wholly owned subsidiary, Disa Digital Safety Pte. Ltd. (&ldquo DiSa&rdquo ), increased its investment in the share capital of Digital Life Line Pte. Ltd. (&ldquo DLL&rdquo ) by subscribing for an additional 70,981,628 new ordinary shares in DLL (&ldquo DLL Shares&rdquo ) in cash at S$0.004926 per DLL Share for a total subscription amount of S$349,656 through a rights issue exercise carried out by DLL (the &ldquo Proposed Additional Investment&rdquo ).
Following the Proposed Additional Investment, DiSa&rsquo s investment in DLL increased by 18.47% from 36.94% to 55.41% (&ldquo Shareholding Increase&rdquo ) and as a result, DLL has become a subsidiary of the Group. The Proposed Additional Investment was funded by the internal resources of the Group.
Incorporated in 2021, DLL is a Singapore-based ISO13485-certified medical technology company that provides digital, AI-powered diagnostic ophthalmology solutions to enable community-based vision screening for early detection and treatment of vision impairment.
On the date of this announcement, DLL has completed the renounceable rights issue exercise and successfully raised S$600,000 for additional working capital purposes. Each existing shareholder of DLL is entitled to two (2) rights for each existing DLL Share held at an issue price of S$0.004926 per DLL Share. The issue price was determined at a discount of around 10% to DLL&rsquo s NTA per share as of 31 January 2024. The Group has participated in the rights issue exercise which resulted in the Proposed Additional Investment.
The Board is of the view that the Proposed Additional Investment is in the best interests of the Company as the issue price is reasonably attractive and allows the Group to increase its control over DLL now to facilitate its participation in DLL&rsquo s ongoing and future projects with potential upside in the future upon successful commercialisation of DLL&rsquo s products. This strategic expansion via DLL into healthcare segment would also help in broadening the revenue streams of the Group. This is in line with the Group&rsquo s aims to deliver sustainable returns for the shareholders as the Group sees business potential in DLL.
|
||
| Useful To Me Not Useful To Me | |||
|
Joelton
Supreme |
13-Mar-2024 09:34
|
||
|
x 0
x 0 Alert Admin |
DiSa Signed Partnership with Asian American Trade Associations Council (&ldquo AATAC&rdquo ) to Combat In-Store Retail Theft across USA with DiSa Smart Case
> The United States of America (&ldquo USA&rdquo ) is deep in what many are calling an epidemic of thefts that costs retailers nearly US$100 billion in 20211
> Designed for simplicity for the ease of use for both consumers and retailers, the DiSa Smart Case has demonstrated to be highly successful in protecting and selling protected substances like alcohol, vapes, and tobacco as well as higher value retail items and other high-theft items during the pilot tests conducted at the retail stores in the USA
> Video demo of DiSa Smart Case can be found here: https://www.youtube.com/watch?v=VFzm2Yb6Yvw
DISA Limited is pleased to announce that DiSa has partnered with AATAC to provide a solution to AATAC&rsquo s retail network that will help combat in-store retail theft by using DiSa Smart Case.
AATAC combines the collective power of thousands of retailers across the country to increase buying power which allows them to offer the best deals and superior service throughout their national network. The partnership with DiSa gives their members access to DiSa Smart Case which was previously only available to mass merchants.
The DiSa Smart Case is the &ldquo no frills, &ldquo retail ready&rdquo , remote locking and unlocking merchandise protection case. It prevents theft by allowing associates to remotely lock or unlock a case using a key fob or a mobile application and thereby protecting the employees from potential robbery incidents while improving employee efficiency. By using the mobile application, associates can schedule specific lock and unlock times in the day and maintain a log of activity.
To prevent sweeping, the case features a &ldquo two-hand operation&rdquo requiring one hand to open the door and another to remove product. It also features shelf blockers to force customers and thieves to remove merchandise one at a time.
In an announcement released to its members last week, Mr. Tony Patel, the Associate Director of AATAC, stated, &ldquo As positive reception to the DiSa Smart Case continues to grow within our network, we expect to soon be able to incorporate this device into hundreds of stores that belong to our Distribution Resolution and Integration Program (&ldquo DRIP&rdquo ). This evolution would allow our delivery representatives to comfortably activate our DRIP sites with higher valued items for resale.&rdquo
&ldquo In our pilot tests conducted at retail stores within the USA, the DiSa Smart Case has shown to eliminate theft on protected items and reduce overall theft by as much as 85% based on the feedback gathered from the participating retailers in the USA&rdquo , said Mr. Jacob
Gulbransen, the Vice President of the USA Sales and Operations of the Group, &ldquo With its ease of use and deployment, we have seen instances that the DiSa Smart Case has improved protection for high-theft items and contributed to the increase in sales for retailers. Hence, it is a perfect solution for the theft issues plaguing the convenience store industry in the USA. We are honoured and delighted to work with AATAC so that their members can effectively use DiSa Smart Case to combat retail theft, enhance their employee safety and improve their retail sales.&rdquo
Mr. Eddie Chng, the Managing Director and Chief Executive Officer of the Group, added, &ldquo Retail theft is a widespread and growing concern that has serious ramifications within the retail industry in the USA, where have seen retail store closures, unsatisfactory consumer experience and a negative impact on employee morale and safety.
DiSa Smart Case is a cost-efficient and safe solution that directly addresses the heart of the problem, and our team will accelerate our efforts to reach out to more retailers in the USA to boost the adoption and deployment of DiSa Smart Cases across the country.&rdquo
The DiSa Smart Case ships &ldquo retail ready&rdquo and can be secured directly to retail shelving or checkout with power and is easily set up and moved by associates.
Designed for simplicity and ease of use, both for consumers and associates, the DiSa Smart Case helps the A
|
||
| Useful To Me Not Useful To Me | |||
|
tonytony
Veteran |
31-Oct-2023 19:49
|
||
|
x 0
x 0 Alert Admin |
Do not subscribe their new rights or warrants , because monies will use to feed them.only | ||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
eddyeddy
Master |
20-Oct-2023 12:14
|
||
|
x 0
x 0 Alert Admin |
This company only feed the BOD and few employees.not the shareholders. | ||
| Useful To Me Not Useful To Me | |||
|
Analysis
Member |
20-Oct-2023 12:07
|
||
|
x 0
x 0 Alert Admin |
To those supporters for Disa , we need higher buy queue at 0.002 in order to see daylight in 10 years time, rest assure all your effort in buy queue at 0.002 that in 10 years time u sure profit in between provided co still around. I can also confirm NO dividend in these 10 years of waiting. DYODD. | ||
| Useful To Me Not Useful To Me | |||
|
Analysis
Member |
20-Oct-2023 09:37
|
||
|
x 0
x 0 Alert Admin |
Disa.. finally at the top list trading....Go Go Go, must have disposed all dispenser to third party. Value for money as an on-going matters . Hopefully make it thru this hard time | ||
| Useful To Me Not Useful To Me | |||
|
dlim888
Member |
12-Oct-2023 16:13
|
||
|
x 0
x 0 Alert Admin |
Eddie Chng has been talking big for the last 7 years and promising big things to come - the only big things that happened have been the many millions of losses each year - irony is that he has been paying himself up to $1m every year at the expense of the suffering investors and shareholders
|
||
| Useful To Me Not Useful To Me | |||
|
eddyeddy
Master |
12-Oct-2023 10:50
|
||
|
x 0
x 0 Alert Admin |
Hopeless to the maximum. | ||
| Useful To Me Not Useful To Me | |||
|
HendriJB
Supreme |
11-Oct-2023 10:49
Yells: "Breathe, Step Back - Think " |
||
|
x 0
x 0 Alert Admin |
|
||
| Useful To Me Not Useful To Me | |||
|
HendriJB
Supreme |
11-Oct-2023 10:45
Yells: "Breathe, Step Back - Think " |
||
|
x 0
x 0 Alert Admin |
How is this working? DiSa receives quality certification mark for saliva-based Covid-19 ART kits -
|
||
| Useful To Me Not Useful To Me | |||
|
HendriJB
Supreme |
11-Oct-2023 10:12
Yells: "Breathe, Step Back - Think " |
||
|
x 0
x 0 Alert Admin |
- - Singapore CNA Podcast - -
11 Oct 2023 09:53 AM
Daily Cuts 9 mins
Health Minister Ong Ye Kung said a few days ago, that Singapore is experiencing a new COVID-19 wave. Meaning more people are expected to fall sick in coming weeks. 3 years ago, we would have made a big deal out of this. But now, we' re focusing on our future response should there be another pandemic. Prime Minister Lee Hsien Loong says is the ' most precious resource' critical in Singapore' s Covid-19 response. One study shows higher levels of trust in the government and among the population means greater compliance with Covid-19 restrictions and higher vaccination rates. Dr Vincent Pang, Assistant Professor, Duke-NUS Medical School, tells Arnold & Andrea that trust is not created overnight. |
||
| Useful To Me Not Useful To Me | |||